Marex Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$410K Buy
+1,841
New +$428K ﹤0.01% 1256
2024
Q3
– Sell
-3,131
Closed -$308K – 650
2024
Q2
$308K Buy
+3,131
New +$319K 0.01% 407
2024
Q1
– Sell
-87,500
Closed -$8.82M – 539
2023
Q4
$8.82M Buy
+87,500
New +$8.68M 0.35% 60
2023
Q1
– Sell
-100,000
Closed -$7.77M – 270
2022
Q4
$7.77M Buy
+100,000
New +$7.6M 1.1% 18

Other funds holding CAH

Marex Group's CAH Position: Q3 2026 in Review

Marex Group opened a new position in Cardinal Health (CAH) in Q3 2026: 1,841 shares worth $410K. The stake represents ﹤0.01% of the portfolio and ranks #1256 among its holdings. This is a return to the name: Marex Group previously reported a position in CAH as recently as Q2 2024.

Marex Group first reported a position in CAH in Q4 2022 and has held it in 4 quarters since. The position peaked at $8.82M in Q4 2023. 1,490 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Marex Group held 1,841 shares of Cardinal Health worth $410K as of Q3 2026.
  • Cardinal Health was a new Marex Group position in Q3 2026.
  • Cardinal Health made up ﹤0.01% of Marex Group's portfolio in Q3 2026, its #1256 holding.
  • Marex Group first reported a position in Cardinal Health in Q4 2022 and has held it in 4 quarters since.
  • Marex Group's Cardinal Health position peaked at $8.82M in Q4 2023.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Marex Group's 13F filing for Q3 2026, filed 16 Nov 2026.